Atreca to Present at Two Upcoming Investor Conferences

    NEXT STORY
    Fortress Biotech Ranked in Top 10 of Deloitte’s 2019 Technology Fast 500™
    PREV STORY
    BioNTech SE Provides Update on Corporate Progress and Third Quarter 2019 Financial Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Final Patient Completes Treatment in Innovation Pharmaceuticals Phase 2 Trial of Brilacidin for Preventing Oral Mucositis in Cancer Patients

    BEVERLY, Mass., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals Inc. (OTCQB:IPIX) (“the Company”), ...

    author_avatar
    NASDAQ Market News

    University of Calgary Joins the Phase II Trial of LSALT Peptide for the Treatment of Complications in Hospitalized COVID-19 Patients

    author_avatar
    NASDAQ Market News

    Pluristem to Present New Data from ARS study at Radiology Conference in U.S.

    HAIFA, Israel, June 29, 2017 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE:PSTI), a ...

    author_avatar
    NASDAQ Market News